← Search & browse all drugs
VARIOUS › DIAGNOSTIC AGENTS › OTHER DIAGNOSTIC AGENTS › Tests for thyreoidea function
thyrotropin
V04CJ01
Forms & Strengths
- Lyophilized powder for injection, 0.9 mg (Thyrogen®)
- Lyophilized powder for injection, 4.5 mg (multiple‑dose vial)
- Reconstituted solution for intravenous or intramuscular administration
Adult Dosing
- Radioiodine ablation: 0.9 mg IM or IV on two consecutive days (total 1.8 mg) after thyroid hormone withdrawal or low‑iodine diet
- Diagnostic whole‑body scan: single 0.9 mg IM or IV dose 24–48 h before radioiodine administration
- Thyroid cancer surveillance: 0.9 mg IM or IV 24–48 h prior to diagnostic I‑131 dose
- Renal impairment (eGFR <30 mL/min): no dosage adjustment, monitor for prolonged TSH elevation
Pediatric Dosing
- Children ≥1 yr, body weight ≥20 kg: single 0.9 mg IM/IV dose for diagnostic scanning (same schedule as adults)
- Children <20 kg: 0.1 mg/kg (maximum 0.9 mg) IM/IV dose, administered 24–48 h before radioiodine
- Use only when benefits outweigh risks; limited safety data below 1 yr
Indications
- Preparation for radioiodine ablation of remnant thyroid tissue in differentiated thyroid cancer
- Facilitation of whole‑body I‑131 scanning for detection of residual or metastatic thyroid tissue
- Diagnostic evaluation of thyroid function in patients post‑thyroidectomy or on suppressive levothyroxine therapy
- Adjunct to improve iodine uptake in low‑iodine diet protocols
Mechanism of Action
- Recombinant human TSH binds the TSH receptor on thyroid follicular cells
- Stimulates cAMP pathway, increasing expression of sodium‑iodide symporter and thyroid peroxidase
- Enhances uptake and organification of radioactive iodine without requiring endogenous TSH rise
Contraindications
- Known hypersensitivity to recombinant human TSH or any excipient
- Pregnancy (risk of fetal thyroid stimulation)
- Breast‑feeding (potential secretion in milk)
- Uncontrolled hyperthyroidism or thyrotoxic crisis
Adverse Reactions
- Injection‑site pain, erythema, or swelling
- Nausea, vomiting, or dyspepsia
- Headache, dizziness, or fatigue
- Transient hyperthyroidism (palpitations, tremor)
- Rare: allergic reactions, anaphylaxis, serum sickness‑like syndrome
Drug Interactions
- Levothyroxine: may blunt TSH response if administered within 24 h of rhTSH
- Glucocorticoids and high‑dose steroids: suppress TSH‑mediated iodine uptake
- Dopamine agonists (e.g., bromocriptine) and somatostatin analogs: reduce TSH secretion and may attenuate rhTSH effect
- Iodinated contrast agents: compete with radioactive iodine uptake, decreasing diagnostic accuracy
- Antithyroid drugs (methimazole, propylthiouracil): may reduce iodine organification after rhTSH
Curated Content: Needs Vetting Before Put to Clinical Use